The notch and TGF-β signaling pathways contribute to the aggressiveness of clear cell renal cell carcinoma

PLoS ONE

Volumn 6, Issue 8, 2011, Pages

  Sjölund, Jonas ^a,d   Boström, Anna Karin ^a   Lindgren, David ^a   Manna, Sugata ^a   Moustakas, Aristidis ^b   Ljungberg, Börje ^c   Johansson, Martin ^a   Fredlund, Erik ^a   Axelson, Håkan ^a  

^a LUND UNIVERSITY   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c UMEÅ UNIVERSITY   (Sweden)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA SECRETASE;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INVASION; CANCER SURVIVAL; CELL MIGRATION; CELLULAR DISTRIBUTION; CLEAR CELL CARCINOMA; CONTROLLED STUDY; CORRELATIONAL STUDY; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE IDENTIFICATION; GENE INTERACTION; GENE LOCATION; HUMAN; HUMAN CELL; KIDNEY CARCINOMA; METASTASIS POTENTIAL; NOTCH GENE; ONCOGENE; PROGNOSIS; PROTEIN TARGETING; SIGNAL TRANSDUCTION; TGF BETA GENE; TRANSCRIPTION REGULATION;

EID: 84856309973     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0023057     Document Type: Article

References (54)

1. Cohen HT, McGovern FJ, (2005) Renal-cell carcinoma. N Engl J Med 353: 2477-2490.
2. Rini BI, Atkins MB, (2009) Resistance to targeted therapy in renal-cell carcinoma. Lancet Oncol 10: 992-1000.
3. Linehan WM, Rubin JS, Bottaro DP, (2009) VHL loss of function and its impact on oncogenic signaling networks in clear cell renal cell carcinoma. Int J Biochem Cell Biol 41: 753-756.
4. Kim WY, Kaelin WG, (2004) Role of VHL gene mutation in human cancer. J Clin Oncol 22: 4991-5004.
5. Bolos V, Grego-Bessa J, de la Pompa JL, (2007) Notch signaling in development and cancer. Endocr Rev 28: 339-363.
6. Nichols JT, Miyamoto A, Weinmaster G, (2007) Notch signaling-constantly on the move. Traffic 8: 959-969.
7. Garber K, (2007) Notch emerges as new cancer drug target. J Natl Cancer Inst 99: 1284-1285.
8. Sjolund J, Johansson M, Manna S, Norin C, Pietras A, et al. (2008) Suppression of renal cell carcinoma growth by inhibition of Notch signaling in vitro and in vivo. J Clin Invest 118: 217-228.
9. Chen CR, Kang Y, Massague J, (2001) Defective repression of c-myc in breast cancer cells: A loss at the core of the transforming growth factor beta growth arrest program. Proc Natl Acad Sci U S A 98: 992-999.
10. Ananth S, Knebelmann B, Gruning W, Dhanabal M, Walz G, et al. (1999) Transforming growth factor beta1 is a target for the von Hippel-Lindau tumor suppressor and a critical growth factor for clear cell renal carcinoma. Cancer Res 59: 2210-2216.
11. Copland JA, Luxon BA, Ajani L, Maity T, Campagnaro E, et al. (2003) Genomic profiling identifies alterations in TGFbeta signaling through loss of TGFbeta receptor expression in human renal cell carcinogenesis and progression. Oncogene 22: 8053-8062.
12. Miyajima A, Asano T, Seta K, Kakoi N, Hayakawa M, (2003) Loss of expression of transforming growth factor-beta receptor as a prognostic factor in patients with renal cell carcinoma. Urology 61: 1072-1077.
13. Takahashi M, Rhodes DR, Furge KA, Kanayama H, Kagawa S, et al. (2001) Gene expression profiling of clear cell renal cell carcinoma: gene identification and prognostic classification. Proc Natl Acad Sci U S A 98: 9754-9759.
14. Kominsky SL, Doucet M, Brady K, Weber KL, (2007) TGF-beta promotes the establishment of renal cell carcinoma bone metastasis. J Bone Miner Res 22: 37-44.
15. Parker AS, Lohse CM, Wu K, Kreinest P, Copland JA, et al. (2007) Lower expression levels of the transforming growth factor beta receptor type II protein are associated with a less aggressive tumor phenotype and improved survival among patients with clear cell renal cell carcinoma. Hum Pathol 38: 453-461.
16. Gonzalez-Garcia S, Garcia-Peydro M, Martin-Gayo E, Ballestar E, Esteller M, et al. (2009) CSL-MAML-dependent Notch1 signaling controls T lineage-specific IL-7R{alpha} gene expression in early human thymopoiesis and leukemia. J Exp Med 206: 779-791.
17. Massague J, Gomis RR, (2006) The logic of TGFbeta signaling. FEBS Lett 580: 2811-2820.
18. Zavadil J, Bitzer M, Liang D, Yang YC, Massimi A, et al. (2001) Genetic programs of epithelial cell plasticity directed by transforming growth factor-beta. Proc Natl Acad Sci U S A 98: 6686-6691.
19. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, et al. (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102: 15545-15550.
20. Breitling R, Armengaud P, Amtmann A, Herzyk P, (2004) Rank products: a simple, yet powerful, new method to detect differentially regulated genes in replicated microarray experiments. FEBS Lett 573: 83-92.
21. Verrecchia F, Chu ML, Mauviel A, (2001) Identification of novel TGF-beta/Smad gene targets in dermal fibroblasts using a combined cDNA microarray/promoter transactivation approach. J Biol Chem 276: 17058-17062.
22. Coulouarn C, Factor VM, Thorgeirsson SS, (2008) Transforming growth factor-beta gene expression signature in mouse hepatocytes predicts clinical outcome in human cancer. Hepatology 47: 2059-2067.
23. Padua D, Zhang XH, Wang Q, Nadal C, Gerald WL, et al. (2008) TGFbeta primes breast tumors for lung metastasis seeding through angiopoietin-like 4. Cell 133: 66-77.
24. Zhao H, Ljungberg B, Grankvist K, Rasmuson T, Tibshirani R, et al. (2006) Gene expression profiling predicts survival in conventional renal cell carcinoma. PLoS Med 3: e13.
25. Laping NJ, Grygielko E, Mathur A, Butter S, Bomberger J, et al. (2002) Inhibition of transforming growth factor (TGF)-beta1-induced extracellular matrix with a novel inhibitor of the TGF-beta type I receptor kinase activity: SB-431542. Mol Pharmacol 62: 58-64.
26. Mitropoulos D, Kiroudi A, Christelli E, Serafetinidis E, Zervas A, et al. (2004) Expression of transforming growth factor beta in renal cell carcinoma and matched non-involved renal tissue. Urol Res 32: 317-322.
27. Jones J, Otu H, Spentzos D, Kolia S, Inan M, et al. (2005) Gene signatures of progression and metastasis in renal cell cancer. Clin Cancer Res 11: 5730-5739.
28. Hegele A, Varga Z, von Knobloch R, Heidenreich A, Kropf J, et al. (2002) TGF-beta1 in patients with renal cell carcinoma. Urol Res 30: 126-129.
29. Sievers E, Dreimuller P, Haferkamp A, Schmidt-Wolf IG, Buchler MW, et al. (2007) Characterization of primary renal carcinoma cultures. Urol Int 79: 235-243.
30. Chen S, Hoffman BB, Lee JS, Kasama Y, Jim B, et al. (2004) Cultured tubule cells from TGF-beta1 null mice exhibit impaired hypertrophy and fibronectin expression in high glucose. Kidney Int 65: 1191-1204.
31. Dudas PL, Argentieri RL, Farrell FX, (2009) BMP-7 fails to attenuate TGF-beta1-induced epithelial-to-mesenchymal transition in human proximal tubule epithelial cells. Nephrol Dial Transplant 24: 1406-1416.
32. Guh JY, Chuang TD, Chen HC, Hung WC, Lai YH, et al. (2003) Beta-hydroxybutyrate-induced growth inhibition and collagen production in HK-2 cells are dependent on TGF-beta and Smad3. Kidney Int 64: 2041-2051.
33. Humes HD, Beals TF, Cieslinski DA, Sanchez IO, Page TP, (1991) Effects of transforming growth factor-beta, transforming growth factor-alpha, and other growth factors on renal proximal tubule cells. Lab Invest 64: 538-545.
34. Massague J, (2008) TGFbeta in Cancer. Cell 134: 215-230.
35. Asano N, Watanabe T, Kitani A, Fuss IJ, Strober W, (2008) Notch1 signaling and regulatory T cell function. J Immunol 180: 2796-2804.
36. Blokzijl A, Dahlqvist C, Reissmann E, Falk A, Moliner A, et al. (2003) Cross-talk between the Notch and TGF-beta signaling pathways mediated by interaction of the Notch intracellular domain with Smad3. J Cell Biol 163: 723-728.
37. Fu Y, Chang A, Chang L, Niessen K, Eapen S, et al. (2009) Differential regulation of transforming growth factor beta signaling pathways by Notch in human endothelial cells. J Biol Chem 284: 19452-19462.
38. Kennard S, Liu H, Lilly B, (2008) Transforming growth factor-beta (TGF- 1) down-regulates Notch3 in fibroblasts to promote smooth muscle gene expression. J Biol Chem 283: 1324-1333.
39. Masuda S, Kumano K, Shimizu K, Imai Y, Kurokawa M, et al. (2005) Notch1 oncoprotein antagonizes TGF-beta/Smad-mediated cell growth suppression via sequestration of coactivator p300. Cancer Sci 96: 274-282.
40. Niimi H, Pardali K, Vanlandewijck M, Heldin CH, Moustakas A, (2007) Notch signaling is necessary for epithelial growth arrest by TGF-beta. J Cell Biol 176: 695-707.
41. Ono Y, Sensui H, Okutsu S, Nagatomi R, (2007) Notch2 negatively regulates myofibroblastic differentiation of myoblasts. J Cell Physiol 210: 358-369.
42. Samon JB, Champhekar A, Minter LM, Telfer JC, Miele L, et al. (2008) Notch1 and TGFbeta1 cooperatively regulate Foxp3 expression and the maintenance of peripheral regulatory T cells. Blood 112: 1813-1821.
43. Sun Y, Lowther W, Kato K, Bianco C, Kenney N, et al. (2005) Notch4 intracellular domain binding to Smad3 and inhibition of the TGF-beta signaling. Oncogene 24: 5365-5374.
44. Zavadil J, Cermak L, Soto-Nieves N, Bottinger EP, (2004) Integration of TGF-beta/Smad and Jagged1/Notch signalling in epithelial-to-mesenchymal transition. Embo J 23: 1155-1165.
45. Real PJ, Tosello V, Palomero T, Castillo M, Hernando E, et al. (2009) Gamma-secretase inhibitors reverse glucocorticoid resistance in T cell acute lymphoblastic leukemia. Nat Med 15: 50-58.
46. Thurston G, Noguera-Troise I, Yancopoulos GD, (2007) The Delta paradox: DLL4 blockade leads to more tumour vessels but less tumour growth. Nat Rev Cancer 7: 327-331.
47. Lindgren D, Liedberg F, Andersson A, Chebil G, Gudjonsson S, et al. (2006) Molecular characterization of early-stage bladder carcinomas by expression profiles, FGFR3 mutation status, and loss of 9q. Oncogene 25: 2685-2696.
48. Hubble J, Demeter J, Jin H, Mao M, Nitzberg M, et al. (2009) Implementation of GenePattern within the Stanford Microarray Database. Nucleic Acids Res 37: D898-901.
49. Fredlund E, Ringner M, Maris JM, Pahlman S, (2008) High Myc pathway activity and low stage of neuronal differentiation associate with poor outcome in neuroblastoma. Proc Natl Acad Sci U S A 105: 14094-14099.
50. Stockhausen MT, Sjolund J, Axelson H, (2005) Regulation of the Notch target gene Hes-1 by TGFalpha induced Ras/MAPK signaling in human neuroblastoma cells. Exp Cell Res 310: 218-228.
51. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, et al. (2002) Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3: RESEARCH0034.
52. Dennler S, Itoh S, Vivien D, ten Dijke P, Huet S, et al. (1998) Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBO J 17: 3091-3100.
53. Aster JC, Robertson ES, Hasserjian RP, Turner JR, Kieff E, et al. (1997) Oncogenic forms of NOTCH1 lacking either the primary binding site for RBP-Jkappa or nuclear localization sequences retain the ability to associate with RBP-Jkappa and activate transcription. The Journal of biological chemistry 272: 11336-11343.
54. Kovacs G, Akhtar M, Beckwith BJ, Bugert P, Cooper CS, et al. (1997) The Heidelberg classification of renal cell tumours. J Pathol 183: 131-133.